Shukra Pharmaceuticals Ltd. | Small-cap | Healthcare
₹34.45
-1.99%
| Shukra Stock Comparison:
Shukra vs Sun PharmaceuticalShukra vs Divi's LaboratoriesShukra vs Suven Life SciencesShukra vs Sequent ScientificShukra vs Aarti DrugsShukra vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 53.9M
Gross Profit 46.2M 85.71%
Operating Income 5.3M 9.86%
Net Income 10.3M 19.10%
EPS (Diluted) ₹0.02

Balance Sheet Metrics

Total Assets 867.7M
Total Liabilities 239.3M
Shareholders Equity 628.4M
Debt to Equity 0.38

Cash Flow Metrics

Revenue & Profitability Trend

Shukra Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i325.9M745.7M588.3M204.9M112.0M
Cost of Goods Sold i81.1M444.9M453.2M103.5M27.7M
Gross Profit i244.8M300.9M135.2M101.4M84.3M
Gross Margin % i75.1%40.3%23.0%49.5%75.3%
Operating Expenses
Research & Development i1.7M1.3M1.2M943.0K529.0K
Selling, General & Administrative i26.8M28.0M6.1M4.4M2.3M
Other Operating Expenses i19.9M16.2M19.9M11.1M18.3M
Total Operating Expenses i48.4M45.5M27.2M16.4M21.2M
Operating Income i97.2M173.5M35.3M12.2M2.4M
Operating Margin % i29.8%23.3%6.0%6.0%2.1%
Non-Operating Items
Interest Income i14.8M5.6M639.0K314.0K467.0K
Interest Expense i5.2M2.8M2.6M2.8M130.0K
Other Non-Operating Income-----
Pre-tax Income i133.4M198.8M44.4M10.2M978.0K
Income Tax i37.6M13.5M432.0K2.7M-902.0K
Effective Tax Rate % i28.2%6.8%1.0%26.3%-92.2%
Net Income i95.8M185.4M44.1M7.5M1.9M
Net Margin % i29.4%24.9%7.5%3.7%1.7%
Key Metrics
EBITDA i168.6M219.6M61.0M29.3M17.8M
EPS (Basic) i₹0.22₹16.93₹6.55₹0.25₹0.06
EPS (Diluted) i₹0.22₹16.93₹6.55₹0.25₹0.06
Basic Shares Outstanding i4378794401094698667259683009536030095360
Diluted Shares Outstanding i4378794401094698667259683009536030095360

Income Statement Trend

Shukra Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i121.2M99.8M39.7M2.9M5.0M
Short-term Investments i121.2M99.8M--34.3M
Accounts Receivable i87.7M245.1M301.9M74.0M97.5M
Inventory i99.5M23.1M31.6M39.5M16.8M
Other Current Assets1.2M796.0K132.2M1.0K1.0K
Total Current Assets i654.3M562.3M530.7M158.7M160.6M
Non-Current Assets
Property, Plant & Equipment i194.0M3.6M3.6M3.3M3.3M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-1.0K35734012.0K-1.3K
Total Non-Current Assets i213.4M216.0M218.9M192.4M195.5M
Total Assets i867.7M778.4M749.7M351.1M356.1M
Liabilities
Current Liabilities
Accounts Payable i92.2M72.2M336.2M85.9M53.3M
Short-term Debt i10.6M5.0M13.1M2.5M0
Current Portion of Long-term Debt-----
Other Current Liabilities42.7M10.1M-1.0K1.0K-
Total Current Liabilities i172.8M141.5M425.1M123.8M70.3M
Non-Current Liabilities
Long-term Debt i31.1M26.6M37.7M31.3M97.7M
Deferred Tax Liabilities i34.1M32.7M32.9M32.6M32.0M
Other Non-Current Liabilities2.0K1.0K1.1M-2.0K-
Total Non-Current Liabilities i66.5M60.4M71.6M63.9M129.7M
Total Liabilities i239.3M202.0M496.7M187.6M200.1M
Equity
Common Stock i437.9M109.5M39.1M15.7M15.7M
Retained Earnings i143.0M375.6M191.1M147.8M140.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i628.4M576.4M253.0M163.5M156.0M
Key Metrics
Total Debt i41.8M31.5M50.8M33.8M97.7M
Working Capital i481.4M420.8M105.7M35.0M90.3M

Balance Sheet Composition

Shukra Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i133.4M198.8M44.4M10.2M978.0K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-57.7M1.5M-287.2M22.3M-487.0K
Operating Cash Flow i66.8M195.1M-245.2M35.0M154.0K
Investing Activities
Capital Expenditures i-27.4M-17.6M-44.9M-15.5M-17.9M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i----0
Investing Cash Flow i-27.4M-17.6M-44.9M-15.5M-17.9M
Financing Activities
Share Repurchases i-----
Dividends Paid i-43.8M-702.0K-728.0K--
Debt Issuance i4.6M-6.4M017.4M
Debt Repayment i--11.1M--63.9M0
Financing Cash Flow i-39.2M126.9M52.0M-63.9M17.4M
Free Cash Flow i51.8M-69.6M-13.2M64.4M-12.5M
Net Change in Cash i145.0K304.4M-238.2M-44.4M-351.0K

Cash Flow Trend

Shukra Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 275.85
Price to Book 25.61
Price to Sales 39.85
PEG Ratio 3.37

Profitability Ratios

Profit Margin 25.68%
Operating Margin 25.25%
Return on Equity 15.24%
Return on Assets 11.04%

Financial Health

Current Ratio 3.79
Debt to Equity 6.65
Beta 0.32

Per Share Data

EPS (TTM) ₹0.13
Book Value per Share ₹1.40
Revenue per Share ₹0.87

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
shukraphar16.0B275.8525.6115.24%25.68%6.65
Sun Pharmaceutical 3.9T36.745.3015.08%19.29%3.26
Divi's Laboratories 1.6T65.3610.0914.64%23.89%0.03
Suven Life Sciences 48.2B-28.0140.49-146.15%84.44%0.00
Sequent Scientific 48.1B166.336.612.84%1.85%62.47
Aarti Drugs 44.5B23.663.2612.28%7.80%44.92

Financial data is updated regularly. All figures are in the company's reporting currency.